Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Allogeneic HSCT
100%
Antibody Therapy
25%
Autologous HSCT
25%
Cancer Cell Targeting
25%
Cause of Death
25%
Cell Therapy
25%
Comorbidity
25%
Disease Relapse
25%
Dual Purpose
25%
Graft-versus-host Disease (GvHD)
100%
Graft-versus-leukemia Effect
100%
Immune Response
25%
Immunomodulatory
25%
Immunosuppression
25%
Methodological Change
25%
Older Patients
25%
Patients with Hematological Malignancies
25%
Pharmacological Agents
25%
Preclinical Modeling
25%
Recurrent Disease
25%
Reduced-intensity Conditioning
25%
Relapse Prevention
50%
Successful Therapy
25%
Unmet Medical Need
25%
Immunology and Microbiology
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Autologous Hematopoietic Stem Cell Transplantation
20%
Cancer Cell
20%
Comorbidity
20%
Conditioning
20%
Cytokine Therapy
20%
Graft Versus Tumor Effect
100%
Graft-Versus-Host Disease
100%
Immune Response
20%
Immunosuppression
20%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
50%
Comorbidity
25%
Cytokine
25%
Diseases
25%
Graft Versus Host Reaction
100%
Hematologic Malignancy
25%
Malignant Neoplasm
25%
Neoplasm
100%
Preclinical Study
25%
Recurrent Disease
25%